Market Research Logo

Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

Report Scope:

The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOCs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets—North America, Europe, Asia-Pacific, and Rest of the World (ROW)—are included.

The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2022.

Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.

Key industry acquisitions and strategic alliances are given for the three-year period from 2015 through 2018.

This report also examines the main patent trends within the industry and profiles 108 proteomics companies.

Report Includes:

- 20 data tables and 62 additional tables
- An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
- Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
- Examination of market trends and opportunities that will impact the future market
- A look at proteomics scientific initiatives, industry acquisitions and patents
- Discussion of proteomic applications in drug discovery and development
- Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
- Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp.


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Information Sources
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Proteomic Technologies
Scope of Report
Proteomics Market
Driving Forces for Proteomics Industry Growth
The Proteomics Industry
Chapter 4 Proteomics Technologies
Introduction
MS-Based Proteomics Technologies
Sample Preparation Assays
Tagging/Affinity Methods
Utility of Proteomics to Identify Biomarkers
MS Instruments and Consumables
Biochip-Based Proteomics Technologies
Multiplex Proteomics Systems
Proteogenomics
Recent Advances in Proteomics Technologies
Chapter 5 Proteomics Applications in Drug Discovery and Development
Target Discovery
Lead Identification
Lead Optimization
Preclinical Studies
Chapter 6 Proteomics Scientific Initiatives
Chapter 7 Clinical Proteomics Applications
Applications in Cancer
Overview
Bladder Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Kidney Cancer
Lung Cancer
Lymphomas
Ovarian Cancer
Prostate Cancer
Thyroid Cancer
Infectious Diseases
Diabetes
Neurological Disorders
Alzheimer's Disease
Schizophrenia
Immune Diseases
HLA Typing
Autoimmune Disease
Cardiovascular Disease
Preeclampsia
Chapter 8 Proteomics Industry
Industry Acquisitions
Industry Strategic Alliances
Mass Spectrometry Industry
Chromatography Industry
Proteomics-Based Drug Discovery and Development Industry
Proteomics Biochip Industries
Peptide Microarray Industry
High-Density Protein Array Industry
Antibody Microarray Industry
China's Biochip Industry
LOC Proteomics Industry
Chemical Proteomics Industry
Antibody Reagent Industry
Multiplex Protein Diagnostics Industry
Dried Blood Spotting Proteomics Industry
Single Cell Proteomics Industry
Chapter 9 Proteomics Markets
Driving Forces of Proteomics Industry Growth
Global Proteomics Markets
Market Summary
Research Market
Drug Discovery and Development Market
Proteomics Diagnostic Market
Mass Spectrometry-Based Proteomics Market
Biochip-Based Proteomics Market
Proteomics Geographic Market
Chapter 10 Proteomics Patents
Protein Array Patents
Lab-on-a-Chip Patents
Mass Spectrometry Patents
Chapter 11 Company Profiles
ABCODIA LTD.
ABLYNX NV (ACQUIRED BY NOVO NORDISK)
ACTIVIOMICS LTD.
ACTIVX BIOSCIENCES INC.
ADVANCED PROTEOME THERAPEUTICS INC.
AGILENT TECHNOLOGIES INC.
APPLIED MICROARRAYS
APPLIED PROTEOMICS
ARRAYIT CORP.
ASTUTE MEDICAL INC.
AVACTA GROUP PLC.
AYOXXA BIOSYSTEMS GMBH
BIOCARTIS NV
BIODESIX INC.
BIOGNOSYS AG
BIOMERIEUX SA
BIOPROXIMITY LLC
BIO-RAD LABORATORIES INC.
BIO-TECHNE INC.
BRUKER CORP.
CAMBRIDGE PROTEIN ARRAYS LTD.
CAPRION BIOSCIENCES INC. (ACQUIRED BY GHO CAPITAL)
CAPROTEC BIOANALYTICS GMBH (ACQUIRED BY CHARLES RIVER LABORATORIES INTERNATIONAL INC.)
CARMENTA BIOSCIENCE INC. (ACQUIRED BY PROGENITY INC.)
CDI LABORATORIES INC.
CRELUX GMBH
CRESCENDO BIOSCIENCE (ACQUIRED BY MYRIAD GENETICS)
CRYSTALGENOMICS INC.
CYVEK INC. (ACQUIRED BY BIO-TECHNE)
DANAHER CORP.
DIASSESS
DIGILAB INC.
EPICYPHER INC.
EVOTEC AG
FLUIDIGM CORP.
GENERAL ELECTRIC CO.
GLAXOSMITHKLINE PLC.
GLOBAL DISCOVERY BIOSCIENCES
GL SCIENCES INC.
HEALTHTELL INC.
HYBRIGENICS SA
IMMUNOVIA AB
IMTAKT CORP.
INTEGRATED DIAGNOSTICS
INDI MOLECULAR
IRIS INTERNATIONAL INC. (ACQUIRED BY DANAHER CORP.)
LABCYTE INC.
LEAP TECHNOLOGIES INC. (ACQUIRED BY TRAJAN SCIENTIFIC AND MEDICAL)
LUMINEX CORP.
MERCK & CO. INC.
MERCK KGAA
MICROLYTIC (ACQUIRED BY ANATRACE)
MRM PROTEOMICS INC.
MOSAIQUES DIAGNOSTICS AND THERAPEUTICS AG
MYCARTIS
MYRIAD GENETICS INC.
NEWOMICS INC.
NIRMIDAS BIOTECH INC.
OLINK BIOSCIENCE
ONCOPLEX DIAGNOSTICS (ACQUIRED BY NANTOMICS)
OPKO HEALTH INC.
PERKINELMER INC.
PERSONALIZED CANCER THERAPY INC.
PFIZER INC.
PHENOMENEX INC.
PHYLOGICA LTD.
PRESSURE BIOSCIENCES INC.
PROMETIC LIFE SCIENCES INC.
PROTAGEN AG
PROTEA BIOSCIENCES INC.
PROTEOCYTE DIAGNOSTICS INC.
PROTEOGENIX
PROTEOME SCIENCES PLC.
PROTEOMICS INTERNATIONAL PTY LTD.
PROTEOVISTA LLC
PROVISTA DIAGNOSTICS INC.
QIAGEN NV
QUANSYS BIOSCIENCES
QUANTERIX INC.
QUEST DIAGNOSTICS INC.
REPLIGEN CORP.
RETROGENIX LTD.
SAMDI TECH INC.
SERA PROGNOSTICS
SHIMADZU CORP.
SHISEIDO COMPANY LTD.
SHOWA DENKO KK
SIGMA ALDRICH (ACQUIRED BY MERCK)
SINGULEX INC.
SISCAPA ASSAY TECHNOLOGIES INC.
SOMALOGIC INC.
SPHERE FLUIDICS LTD.
SPOTON CLINICAL DIAGNOSTICS LTD.
SQI DIAGNOSTICS
SYNAGEVA BIOPHARMA (ACQUIRED BY ALEXION PHARMACEUTICALS INC.)
T2 BIOSYSTEMS
THERANOSTICS HEALTH (ACQUIRED BY AVANT DIAGNOSTICS)
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TOSOH CORP.
UNIVERSAL BIOSENSORS LTD.
VERMILLION INC.
VG LIFE SCIENCES INC.
WATERS CORP.
XENCOR INC.
YMC CO. LTD.
ZEPHYRUS BIOSCIENCES INC. (ACQUIRED BY BIO-TECHNE CORP.)
List of Tables
Summary Table : Global Proteomics Market, by End-User Industry, Through 2022
Table 1 : Global Array versus LOC Biochips
Table 2 : Scope of Report
Table 3 : Global Proteomics Market by Platform, Through 2022
Table 4 : Driving Forces in the Growth of the Proteomics Industry
Table 5 : Biochip Industry Comparisons
Table 6 : Mass Spectrometry Generalized Workflow Schematic
Table 7 : Mass Spectrometer Platforms
Table 8 : Biochip-Based Proteomics Technologies
Table 9 : Planar-Based Versus Bead-Based Arrays
Table 10 : Advantages of Multiplexing for Diagnostics
Table 11 : Technical Advances in Proteomics
Table 12 : Proteomic Applications in Drug Discovery and Development
Table 13 : Large-Scale Proteomics Initiatives
Table 14 : Some of the Cancer Markers used in Diagnosis and Treatment
Table 15 : Strategies for Overcoming High-Abundance Proteins in Clinical Samples
Table 16 : Estimated U.S. Incidence and Deaths for Selected Cancers, 2010, 2013 and 2018
Table 17 : Status of Next-Generation Diagnostic Tests for Bladder Cancer
Table 18 : Estimated Number of Annual Breast Cancer Treatment Decisions in the U.S., by Cancer Classification
Table 19 : Breast Cancer MDx Technology Platforms
Table 20 : Status of Next-Generation Diagnostic Tests for Gastric/Stomach Cancer
Table 21 : Status of Next-Generation Diagnostic Tests for Kidney Cancer
Table 22 : Five-Year Survival Rates for Non-Small Cell Lung Cancer, 2012-2017
Table 23 : Status of Next-Generation Diagnostic Tests for Lung Cancer
Table 24 : Status of Next-Generation Diagnostic Tests for Lymphomas
Table 25 : Early Screening Tests for Ovarian Cancer
Table 26 : Status of Next-Generation Diagnostics Tests for Ovarian Cancer
Table 27 : Status of Next-Generation Diagnostics Tests for Pan-Cancer
Table 28 : Status of Next-Generation Diagnostics Tests for Prostate Cancer
Table 29 : Status of Next-Generation Diagnostics Tests for Thyroid Cancer
Table 30 : Alzheimer's Disease Diagnostic Approaches
Table 31 : Multiplex Autoimmune Testing Market
Table 32 : Preeclampsia Diagnostic Tests
Table 33 : Proteomics Industry Acquisitions, 2015-2018
Table 34 : Strategic Alliances in the Proteomics Industry, 2015 -2018
Table 35 : Mass Spectrometry Industry: Porter’s Five Forces Analysis
Table 36 : First-Tier Mass Spectrometry Companies
Table 37 : Second-Tier Mass Spectrometry Companies
Table 38 : Leading Manufacturers of High-Performance Liquid Chromatography Columns
Table 39 : Leading Manufacturers of High-Performance Liquid Chromatography Columns in Japan
Table 40 : Proteomics-Based Drug Discovery Industry
Table 41 : Key Peptide Microarray Companies
Table 42 : Leading High-Density Protein Array Companies
Table 43 : Key Antibody Microarray Companies
Table 44 : Leading Companies in China's Biochip Industry
Table 45 : LOC Competitor Landscape
Table 46 : Antibody Reagent Market, 2016
Table 47 : Multiplex Protein In Vitro Diagnostics Companies
Table 48 : Dried Blood Spot Proteomics Industry
Table 49 : Single Cell Proteomics Industry
Table 50 : Factors driving the growth of the Proteomics Industry
Table 51 : Global Proteomic Market, by End-User Industry, Through 2022
Table 52 : Global Proteomics Research Market, by Platform, Through 2022
Table 53 : Global Proteomics Research Market, by Biochip Platform, Through 2022
Table 54 : Global Proteomics Drug Discovery and Development Market, by Platform, Through 2022
Table 55 : Global Proteomics Biochip Drug Discovery and Development Market, by Biochip Type, Through 2022
Table 56 : Global Proteomics Diagnostic Market, by Platform, Through 2022
Table 57 : Global Proteomics Diagnostic Market, by Biochip Type, Through 2022
Table 58 : Global Proteomics Diagnostic Market, by Disease Type, Through 2022
Table 59 : Status of Proteomics-Based Diagnostics for Diabetes, Neurological, Autoimmune, Infectious Disease, HLA Typing, and Cardiovascular Disease Applications
Table 60 : Sepsis Diagnostics Industry
Table 61 : Global Proteomics Cancer Diagnostic Market, by Indication, Through 2022
Table 62 : Global Mass Spectrometry Market, by Product Type, Through 2022
Table 63 : Global Mass Spectrometry Market, by End-User Industry, Through2022
Table 64 : MRM-MS versus MALDI MS in Clinical Applications
Table 65 : Status of MS Clinical Test Platforms
Table 66 : Phosphoproteomics Platforms for Cancer Applications
Table 67 : Global Mass Spectrometry Instrument Market for Proteomics, by Technique, Through 2022
Table 68 : Global Mass Spectrometry Consumable Market, by Type, Through 2022
Table 69 : Global Proteomics Biochip Market, by Platform, Through 2022
Table 70 : Global Proteomics Arrays Market, by Type, Through 2022
Table 71 : Global Proteomics Biochips Market, by End-User Industry, Through 2022
Table 72 : Global Proteomics Array Market, by End-User Industry, Through 2022
Table 73 : lobal Proteomics LOC Market, by End-User Industry, Through 2022
Table 74 : Global Proteomics Market, by Region, Through 2022
Table 75 : Global Proteomic Diagnostic Market, by Region, Through 2022
Table 76 : Array-related Proteomics Patents by Region, 2015–2018
Table 77 : LOC-related Proteomics Patents by Region, 2015-2018
Table 78 : Mass Spectrometry-Related Proteomics Patents, by Region, 2015-2018
Table 79 : Applications for Y2H and YChemH Proteomics Platforms
Table 80 : Somalogic Proteomics Methods
Table 81 : Universal Biosensors Diagnostic Pipeline
List of Figures
Summary Figure : Global Proteomics Market, by End-User Industry, 2016-2022
Figure 1 : Proteomics Biochip and Array Formats
Figure 2 : Chromatography Proteomics Workflow

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report